Prior Information Notice: Long-term stockpiling of active pharmaceutical ingredients (APIs) and rapid production of finished dose forms

HaDEA has published the Prior Information Notice (PIN) HADEA/2026/OP/0021-PIN: Long-term API stockpiling and rapid finished dose form manufacture. 

This upcoming call for tenders aims to support the development of and access to technologies that can prolong the shelf-life of active pharmaceutical ingredients (APIs) stored in bulk while advancing manufacturing technologies to produce finished dose forms from those bulk APIs rapidly. The goal is to enhance crisis preparedness by exploring potential gains in sustainability, resiliency, and flexibility to respond to future health emergencies. 

The call will request the development of a pilot feasibility project to test this concept, assess its viability and provide recommendations on how to operationalise the approach. Among other tasks, tenderers will be expected to develop a rapid manufacturing process for finished dose forms, as well as stability studies to demonstrate feasibility of long-term storing of APIs. 

Indicative budget: € 6 000 000 

Interested parties are invited to consult the EU Funding and Tenders Portal for the future publication of the contract notice and tender documents in May 2026.

Background 

EU4Health is the fourth and largest of the EU health programmes. The EU4Health programme goes beyond an ambitious response to the COVID-19 crisis to address the resilience of European healthcare systems. The programme provides funding to national authorities, health organisations and other bodies through grants and public procurement, contributing to a healthier Europe. 

HaDEA manages the vast majority of the total EU4Health budget and implements the programme by managing calls for proposals and tenders from 2021 to 2027.